190 related articles for article (PubMed ID: 20335448)
1. A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain.
Nader N; Bachrach BE; Hurt DE; Gajula S; Pittman A; Lescher R; Kino T
J Clin Endocrinol Metab; 2010 May; 95(5):2281-5. PubMed ID: 20335448
[TBL] [Abstract][Full Text] [Related]
2. A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance.
Charmandari E; Kino T; Ichijo T; Jubiz W; Mejia L; Zachman K; Chrousos GP
J Clin Endocrinol Metab; 2007 Oct; 92(10):3986-90. PubMed ID: 17635946
[TBL] [Abstract][Full Text] [Related]
3. A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities.
Nicolaides NC; Roberts ML; Kino T; Braatvedt G; Hurt DE; Katsantoni E; Sertedaki A; Chrousos GP; Charmandari E
J Clin Endocrinol Metab; 2014 May; 99(5):E902-7. PubMed ID: 24483153
[TBL] [Abstract][Full Text] [Related]
4. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.
Charmandari E; Raji A; Kino T; Ichijo T; Tiulpakov A; Zachman K; Chrousos GP
J Clin Endocrinol Metab; 2005 Jun; 90(6):3696-705. PubMed ID: 15769988
[TBL] [Abstract][Full Text] [Related]
5. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
[TBL] [Abstract][Full Text] [Related]
6. Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene.
Mendonca BB; Leite MV; de Castro M; Kino T; Elias LL; Bachega TA; Arnhold IJ; Chrousos GP; Latronico AC
J Clin Endocrinol Metab; 2002 Apr; 87(4):1805-9. PubMed ID: 11932321
[TBL] [Abstract][Full Text] [Related]
7. Three Novel Heterozygous Point Mutations of NR3C1 Causing Glucocorticoid Resistance.
Vitellius G; Fagart J; Delemer B; Amazit L; Ramos N; Bouligand J; Le Billan F; Castinetti F; Guiochon-Mantel A; Trabado S; Lombès M
Hum Mutat; 2016 Aug; 37(8):794-803. PubMed ID: 27120390
[TBL] [Abstract][Full Text] [Related]
8. Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in Helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1).
McMahon SK; Pretorius CJ; Ungerer JP; Salmon NJ; Conwell LS; Pearen MA; Batch JA
J Clin Endocrinol Metab; 2010 Jan; 95(1):297-302. PubMed ID: 19933394
[TBL] [Abstract][Full Text] [Related]
9. A NOVEL GLUCOCORTICOID RECEPTOR MUTATION IN PRIMARY GENERALIZED GLUCOCORTICOID RESISTANCE DISEASE.
Ma L; Tan X; Li J; Long Y; Xiao Z; De J; Ren Y; Tian H; Chen T
Endocr Pract; 2020 Jun; 26(6):651-659. PubMed ID: 32045292
[No Abstract] [Full Text] [Related]
10. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance.
Ruiz M; Lind U; Gåfvels M; Eggertsen G; Carlstedt-Duke J; Nilsson L; Holtmann M; Stierna P; Wikström AC; Werner S
Clin Endocrinol (Oxf); 2001 Sep; 55(3):363-71. PubMed ID: 11589680
[TBL] [Abstract][Full Text] [Related]
11. A novel point mutation in the DNA-binding domain (DBD) of the human glucocorticoid receptor causes primary generalized glucocorticoid resistance by disrupting the hydrophobic structure of its DBD.
Roberts ML; Kino T; Nicolaides NC; Hurt DE; Katsantoni E; Sertedaki A; Komianou F; Kassiou K; Chrousos GP; Charmandari E
J Clin Endocrinol Metab; 2013 Apr; 98(4):E790-5. PubMed ID: 23426617
[TBL] [Abstract][Full Text] [Related]
12. First High-Resolution Crystal Structures of the Glucocorticoid Receptor Ligand-Binding Domain-Peroxisome Proliferator-Activated
Liu X; Wang Y; Ortlund EA
Mol Pharmacol; 2019 Oct; 96(4):408-417. PubMed ID: 31391291
[TBL] [Abstract][Full Text] [Related]
13. Familial glucocorticoid resistance caused by a novel frameshift glucocorticoid receptor mutation.
Trebble P; Matthews L; Blaikley J; Wayte AW; Black GC; Wilton A; Ray DW
J Clin Endocrinol Metab; 2010 Dec; 95(12):E490-9. PubMed ID: 20861124
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid resistance in premature pubarche and adolescent hyperandrogenism.
Witchel SF; Smith RR
Mol Genet Metab; 1999 Feb; 66(2):137-41. PubMed ID: 10068517
[TBL] [Abstract][Full Text] [Related]
15. Structural Analysis on the Pathologic Mutant Glucocorticoid Receptor Ligand-Binding Domains.
Hurt DE; Suzuki S; Mayama T; Charmandari E; Kino T
Mol Endocrinol; 2016 Feb; 30(2):173-88. PubMed ID: 26745667
[TBL] [Abstract][Full Text] [Related]
16. Doubling the size of the glucocorticoid receptor ligand binding pocket by deacylcortivazol.
Suino-Powell K; Xu Y; Zhang C; Tao YG; Tolbert WD; Simons SS; Xu HE
Mol Cell Biol; 2008 Mar; 28(6):1915-23. PubMed ID: 18160712
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of the hGRαT556I causing Chrousos syndrome.
Nicolaides NC; Skyrla E; Vlachakis D; Psarra AM; Moutsatsou P; Sertedaki A; Kossida S; Charmandari E
Eur J Clin Invest; 2016 Jan; 46(1):42-9. PubMed ID: 26541474
[TBL] [Abstract][Full Text] [Related]
18. A Natural Mutation in Helix 5 of the Ligand Binding Domain of Glucocorticoid Receptor Enhances Receptor-Ligand Interaction.
Reyer H; Ponsuksili S; Kanitz E; Pöhland R; Wimmers K; Murani E
PLoS One; 2016; 11(10):e0164628. PubMed ID: 27736993
[TBL] [Abstract][Full Text] [Related]
19. Single Nucleotide Variations of the Human GR Gene Manifested as Pathologic Mutations or Polymorphisms.
Kino T
Endocrinology; 2018 Jul; 159(7):2506-2519. PubMed ID: 29762667
[TBL] [Abstract][Full Text] [Related]
20. Familial glucocorticoid receptor haploinsufficiency by non-sense mediated mRNA decay, adrenal hyperplasia and apparent mineralocorticoid excess.
Bouligand J; Delemer B; Hecart AC; Meduri G; Viengchareun S; Amazit L; Trabado S; Fève B; Guiochon-Mantel A; Young J; Lombès M
PLoS One; 2010 Oct; 5(10):e13563. PubMed ID: 21042587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
